Omnia Education
Omnia Education is exclusively focused on women’s health and the ways in which diseases and conditions impact the female patient. That unique focus on the female patient has allowed Omnia Education to transform the CME learning environment for healthcare professionals nationwide. Our leading position in women's health education is evidence of our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes. Ultimately, our education improves clinician knowledge, awareness, attitudes, competencies, and performance in practice.
1-15 of 15
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
CME/CE Broadcast ReplayENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Diagnosing and Treating IBS: It Begins With One Simple Question
CME/CE Broadcast ReplayDiagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
CME/CEThe Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
William Goodnight, MD, MSCR
Kara B. Markham, MD
Karin J. Blakemore, MD
Emilie L. Vander Haar
Karin J. Blakemore, MD
Emilie L. Vander Haar
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
CME/CE Broadcast ReplayOptimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Kristina Deligiannidis, MD
Jennifer L. Payne, MD
- advertisement
Love Story: Lipid Education for Women’s Heart Health
CME/CE Broadcast ReplayLove Story: Lipid Education for Women’s Heart Health
Pam R. Taub, MD, FACC, FASPC
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
CME/CEInnovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Kara B. Markham, MD
Kenneth J. Moise Jr., MD
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
CME/CEWhy Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Lee P. Shulman, MD, FACMG, FACOG
Roberto Romero, MD, DMedSci
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
CME/CEParallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Lee P. Shulman, MD, FACMG, FACOG
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
Alloimmune Neutropenia of the Fetus and Newborn
CME/CEAlloimmune Neutropenia of the Fetus and Newborn
Lee P. Shulman, MD, FACMG, FACOG
Masja de Haas, MD, PhD
Alloimmune Thrombocytopenia in the Fetus and Newborn
CME/CEAlloimmune Thrombocytopenia in the Fetus and Newborn
Lee P. Shulman, MD, FACMG, FACOG
James B. Bussel, MD
- advertisement
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
CME/CETargeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Lee P. Shulman, MD, FACMG, FACOG
Kenneth J. Moise Jr., MD
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
CME/CERed Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
Lee P. Shulman, MD, FACMG, FACOG
Kenneth J. Moise Jr., MD
Primary HPV Screening: A Nurse Practitioner’s Perspective
Video LibraryPrimary HPV Screening: A Nurse Practitioner’s Perspective
